Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income		$ 5,787,000	$ 6,359,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	[1]	1,542,000	1,447,000
Deferred income tax expense (benefit)	[1]	1,860,000	(246,000)
Reserve for uncertain tax positions	[1]	76,000	133,000
Non-cash share-based compensation expense (benefit)	[1]	171,000	(36,000)
Change in fair value of contingent consideration	[1]	31,000	0
Loss on extinguishment of debt		67,000	0
Amortization of debt issuance costs		15,000	9,000
Net changes in assets and liabilities:
Trade accounts receivable		(272,000)	1,251,000
Prepaid expenses and other current and long-term assets		(2,419,000)	(1,620,000)
Deferred contract costs, net		24,000	199,000
Operating lease assets and liabilities, net		(26,000)	(22,000)
Accounts payable		627,000	(151,000)
Accrued expenses, wages and bonuses		(472,000)	2,482,000
Income taxes receivable and payable		(80,000)	1,872,000
Deferred revenue		(285,000)	360,000
Net cash provided by operating activities		6,646,000	12,037,000
Cash flows from investing activities:
Purchases of property and equipment		(2,986,000)	(4,138,000)
Net cash used in investing activities		(2,986,000)	(4,138,000)
Cash flows from financing activities:
Borrowings on notes payable		27,738,000	0
Payments on notes payable		(28,724,000)	(1,621,000)
Borrowings on revolving loan		8,000,000	13,000,000
Payments on revolving loan		(4,503,000)	(6,000,000)
Payment of debt issuance costs		(62,000)	0
Payments on finance lease obligations		(2,000)	(11,000)
Proceeds from the exercise of share-based awards		132,000	0
Payment of payroll tax withholdings on share-based awards exercised		0	(317,000)
Payment of acquisition contingent consideration		(280,000)	0
Repurchase of shares for treasury		(4,920,000)	(14,999,000)
Payment of dividends on common stock		(2,770,000)	(2,906,000)
Net cash used in financing activities		(5,391,000)	(12,854,000)
Effect of exchange rate changes on cash and cash equivalents		0	1,000
Change in cash and cash equivalents		(1,731,000)	(4,954,000)
Cash and cash equivalents at beginning of period		4,233,000	6,653,000
Cash and cash equivalents at end of period		2,502,000	1,699,000
Supplemental disclosure of cash paid for:
Interest expense, net of capitalized amounts		774,000	521,000
Income taxes		80,000	78,000
Supplemental disclosure of non-cash investing and financing activities:
Stock tendered to the Company for cashless exercise of stock options in connection with equity incentive plans		0	1,752,000
Purchase of property and equipment in accounts payable and accrued expenses		2,131,000	2,664,000
Repurchase of shares for treasury in accounts payable and accrued expenses		47,000	152,000
Debt issuance costs included in accrued expenses		81,000	0
Debt extinguished with new debt		34,396,000	0
Noncash borrowings on long-term debt for accrued interest and debt issuance costs		$ 351,000	$ 0

[1] Other significant expenses are also included within the team expenses captions such as associate and other operating expenses.